Science Weekly
The Guardian
Stateside with Kai and Carter: Stacey Abrams on why gutting of the US Voting Rights Act is ‘evil’
In the inaugural episode of Stateside, hosts Kai and Carter explore the recent erosion of the US Voting Rights Act and the severe implications for American democracy. Joined by political activist and organizer Stacey Abrams, the hosts discuss the legal landscape following recent Supreme Court rulings that have effectively stripped away federal protections, making it significantly harder to challenge discriminatory voting laws. Abrams offers a sobering assessment of the situation, characterizing these legislative and judicial moves not merely as partisan politics, but as a calculated descent into competitive authoritarianism. She reframes the current crisis by shifting the focus from optimism—which she describes as an ebb-and-flow sentiment—to determination, urging citizens to treat the fight for voting rights as a long-term, non-negotiable enterprise. Throughout the discussion, Abrams emphasizes that while the legal "cheat code" of the Voting Rights Act may be gone, the fundamental work of building multi-racial coalitions, engaging underserved communities, and maintaining pressure at both the local and national levels remains the only viable path to securing representation and accountability in the face of systemic voter suppression.
Updated May 18, 2026
About This Episode
Listen to Science Weekly in Podtastic
For listeners, not advertisers
More Episodes
Are robots nearing their ChatGPT moment?
In this episode of Science Weekly, host Ian Sample explores whether the field of robotics is finally approaching its ChatGPT moment. The discussion highlights the rapid acceleration of robotic technology in China, where government-backed investment and a robust manufacturing supply chain have turned the country into a global leader in embodied AI. While humanoid robots are already gaining attention for performing feats like running races and martial arts, experts clarify that the true goal is to develop machines capable of navigating complex, unpredictable environments like households and factories. The conversation identifies the primary technical hurdle as achieving human-like dexterity, particularly in the design of robot hands and sophisticated sensing technology. Guests Amy Hawkins and Professor Nathan Lapora discuss how researchers are currently training robots using human-captured data to overcome these challenges. The episode also touches on the societal implications of this shift, including labor market concerns, the potential for autonomous factories, and the role of robots in addressing the needs of an aging population. Ultimately, while robots are not yet common in daily life, the rapid integration of advanced AI and hardware suggests a significant transformation in how these machines will interact with the physical world.
Do red-light masks really keep you looking young?
In this episode of Science Weekly, the host examines the surge in popularity of at-home red-light therapy masks, exploring whether these devices truly offer the anti-aging benefits they claim. The discussion traces the origins of photobiomodulation back to accidental discoveries in the 1960s and 1990s, where researchers noted unexpected hair growth in lab mice and accelerated wound healing in space scientists. The core scientific premise is that red light penetrates the skin to stimulate mitochondria, theoretically boosting cell metabolism and collagen production. While dermatological experts acknowledge that this mechanism has biological potential, they emphasize a significant gap between controlled laboratory results on individual cells and the practical efficacy of consumer-grade masks. The experts point to a lack of standardized clinical trials regarding dosage, intensity, and frequency, leading to the conclusion that while the field is promising, it currently lacks robust evidence to support drastic aesthetic claims. Beyond skincare, the episode also touches on future medical research into red light for conditions like vision loss, brain injury, and muscle repair, though these applications remain in early experimental stages.
Stateside with Kai and Carter: why the fight over abortion pills is only just beginning
In this episode of Science Weekly, hosts Kai and Carter delve into the ongoing legal and political battle surrounding abortion pills in the United States. Following the Supreme Court’s decision to temporarily maintain access to mifepristone, the hosts explain why this ruling serves as a temporary reprieve rather than a resolution. They argue that the fight over medication abortion is only just beginning, with multiple legal challenges still looming in lower courts. The discussion features insights from Dr. Angel Foster, an abortion provider who leads a medication access project, highlighting how providers operate under the protection of state shield laws while facing increasing risks. The episode explores the shift in anti-abortion rhetoric, noting that previously unthinkable concepts—such as the criminalization of abortion patients—are gradually entering mainstream political discourse. By examining the impact of these legal uncertainties on patients, particularly those in vulnerable situations, the hosts emphasize the resilience of grassroots networks while warning that the anti-abortion movement continues to develop sophisticated strategies to restrict access nationwide. Ultimately, the episode serves as a cautionary analysis of how quickly legal landscapes can shift and why sustained attention to these developments is critical.
Can a name change transform PCOS outcomes for women?
This episode explores the significant transition of Polycystic Ovary Syndrome (PCOS) to its new designation, Polymetabolic Ovarian Syndrome (PMOS). The hosts discuss why the original name was medically misleading, as it falsely centered the condition on ovarian cysts and reproductive health, ignoring the complex hormonal and metabolic issues that define the experience. By categorizing the condition incorrectly, the medical establishment often mismanaged patient care, leading to widespread confusion, inadequate support, and diagnostic delays for millions of women. The discussion highlights the decade-long global campaign, involving patients and healthcare professionals, to secure a name that more accurately reflects the condition’s nature as a multi-system health issue. Experts explain that the shift to PMOS is designed to move the condition out of the narrow reproductive box and into a framework that accounts for its lifelong impact, including insulin resistance, dermatological symptoms, and cardiovascular risks. Through the personal account of a patient advocate, the episode illustrates how this labeling shift is not merely symbolic, but a vital step toward securing better funding, education, and medical recognition for those living with the condition.
Ebola: how does it spread and can the outbreak be contained?
In this episode of Science Weekly, host Ian Sample examines an Ebola outbreak in the Democratic Republic of Congo that has been declared a public health emergency of international concern. Joining him is clinical epidemiologist Dr. Daniela Manno, who explains that this particular outbreak is caused by the rare Bundibugyo strain. Because this strain is uncommon, there are currently no specific vaccines or targeted therapeutics available for treatment, making containment particularly challenging. The discussion explores how Ebola spreads through direct contact with infected bodily fluids and why wildlife spillover events are becoming more frequent due to environmental encroachment and shifting land use. Dr. Manno highlights that while traditional outbreak response methods—such as contact tracing, isolation, and safe burial practices—are effective, they face hurdles in the region, including civil insecurity, weak healthcare infrastructure, and the necessity for culturally sensitive community engagement. The episode emphasizes the urgent need for a coordinated international response to track the outbreak’s true scale and implement containment strategies to prevent further regional spread in densely populated areas.
Hantavirus update, Pentagon’s UFO files, can art slow biological ageing?
In this episode of Science Weekly, the hosts delve into three distinct topics ranging from public health concerns to government transparency and the science of longevity. The discussion begins with an update on the Hantavirus outbreak aboard the cruise ship MV Hondias. The hosts examine the latest case figures, the current quarantine measures for passengers, and the genetic evidence suggesting the outbreak originated from a single spillover event involving infected rodents. While health organizations remain vigilant, experts clarify that the risk to the general public is low. The conversation then shifts to the recent declassification of US government files concerning unidentified anomalous phenomena, or UFOs. The hosts explore the nature of the released materials—ranging from eyewitness reports to photographs—and discuss why these phenomena remain difficult to explain, despite no definitive proof of extraterrestrial visitation. Finally, the episode highlights a study from University College London investigating the link between cultural engagement and biological aging. While the researchers found a correlation between frequent participation in arts and crafts and slower biological aging, the hosts emphasize the complexities of observational research and the potential for reverse causality in such findings.
Strange trip: why Trump is backing psychedelics
In this episode of Science Weekly, host Madeline Finley explores the unexpected intersection of the Trump administration and the burgeoning psychedelic industry. The discussion centers on a recent executive order aimed at accelerating medical research into psychedelic substances, particularly ibogaine, which has gained significant traction among veteran groups seeking relief from PTSD and traumatic brain injuries. Journalist Maitha Busby provides context on this surprising policy shift, noting how the advocacy of veterans and influential figures like Joe Rogan has successfully shifted the conversation around psychedelics from the countercultural left to the political right. The episode examines the mechanics of the executive order, which earmarks research funding, creates a path for end-of-life patients to access these treatments, and initiates a review process for potential rescheduling. Beyond the political dynamics, the conversation touches on the global origins of these plants, the concerns regarding the appropriation of indigenous knowledge, and the potential impact on the pharmaceutical industry. Ultimately, the episode considers whether this marks a turning point in the long-standing war on drugs, despite ongoing legal hurdles and ideological divisions within the current political landscape.
100 years on Earth: celebrating David Attenborough’s birthday
In this episode of Science Weekly, host Madeline Finley and natural history writer Patrick Barkham celebrate the impending 100th birthday of Sir David Attenborough. The discussion explores the vast changes the planet has undergone during Attenborough's lifetime, moving from the Holocene to the Anthropocene, marked by significant biodiversity loss and increased human consumption. The conversation highlights Attenborough’s accidental transition from a producer to an iconic presenter, particularly through his landmark series Life on Earth. Barkham explains how Attenborough’s approach to filmmaking has evolved; while his early work reflected a neutral, observational style, his recent projects have become explicitly environmental, often reflecting and helping shift the public mood regarding climate change and conservation. Beyond his filmography, the episode emphasizes Attenborough’s immense influence on the global conservation movement. Many modern scientists cite him as their primary inspiration, and his ability to advocate for the planet has uniquely pressured world leaders. Ultimately, the hosts reflect on Attenborough’s enduring curiosity and dedication as a blueprint for longevity, concluding that his legacy is not only found in his vast body of work but in the countless individuals he has inspired to protect the natural world.
Related Podcasts
All podcast names and trademarks are the property of their respective owners. Podcasts listed on Podtastic are publicly available shows distributed via RSS. Podtastic does not endorse nor is endorsed by any podcast or podcast creator listed in this directory.